Business Standard

Sun Pharma nears 52-week high ahead of Q3 results; stock up 7% in a month

In the past one month, Sun Pharma outperformed market as shares surged 7 per cent, as compared to 2.5 per cent decline in the S&P BSE Sensex

Sun Pharma
Premium

SI Reporter Mumbai
Shares of Sun Pharmaceutical Industries gained 2.5 per cent to Rs 1,069.40 in Monday’s intra-day trade and quoted close its 52-week high level ahead of the December quarter results (Q3FY23) due Tuesday, January 31, 2023. In comparison, the S&P BSE Sensex was down 0.24 per cent at 59,185 at 11:17 am.

The stock of healthcare company had hit 52-week high of Rs 1,071 on November 2, 2022. In the past one month, it outperformed market as shares surged 7 per cent, as compared to 2.5 per cent decline in the S&P BSE Sensex. The stock had hit a record

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jan 30 2023 | 11:56 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com